Race Oncology Limited (ASX: RAC)

Race Oncology Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	17.19	17.19	21.52	33.54	9.32	1.73
Cash & Short-Term Investments	17.19	17.19	21.52	33.54	9.32	1.73
Cash Growth	-20.13%	-20.13%	-35.84%	259.79%	438.63%	75.05%
Other Receivables	0.11	0.11	1.7	0.06	0.13	0.05
Receivables	0.11	0.11	1.7	0.06	0.13	0.05
Prepaid Expenses	0.12	0.12	0.32	0.55	1.14	0.03
Other Current Assets	-	-	-	-	-	0.18
Total Current Assets	17.42	17.42	23.54	34.15	10.59	2
Other Intangible Assets	2.81	2.81	3.09	3.37	3.66	3.94
Total Assets	20.23	20.23	26.64	37.52	14.25	5.93
Accounts Payable	1.2	1.2	0.64	0.83	0.31	0.13
Accrued Expenses	0.67	0.67	0.51	0.58	0.21	0.11
Total Current Liabilities	1.87	1.87	1.15	1.42	0.52	0.24
Other Long-Term Liabilities	0.05	0.05	-	-	-	-
Total Liabilities	1.92	1.92	1.15	1.42	0.52	0.24
Common Stock	66.95	66.95	61.71	62.02	31.5	19.66
Retained Earnings	-57.42	-57.42	-43.6	-33.68	-22.47	-15.77
Comprehensive Income & Other	8.78	8.78	7.38	7.77	4.69	1.8
Shareholders' Equity	18.31	18.31	25.49	36.11	13.72	5.69
Total Liabilities & Equity	20.23	20.23	26.64	37.52	14.25	5.93
Net Cash (Debt)	17.19	17.19	21.52	33.54	9.32	1.73
Net Cash Growth	-20.13%	-20.13%	-35.84%	259.79%	438.63%	75.05%
Net Cash Per Share	0.10	0.10	0.13	0.22	0.07	0.02
Filing Date Shares Outstanding	170.39	170.39	163.07	159.52	144.4	122.77
Total Common Shares Outstanding	170.3	170.3	163.07	159.52	143.65	116.45
Working Capital	15.55	15.55	22.39	32.73	10.07	1.75
Book Value Per Share	0.11	0.11	0.16	0.23	0.10	0.05
Tangible Book Value	15.5	15.5	22.39	32.73	10.07	1.75
Tangible Book Value Per Share	0.09	0.09	0.14	0.21	0.07	0.02

Source: S&P Capital IQ. Standard template. Financial Sources.